Y Intercept Hong Kong Ltd Buys New Shares in Exponent, Inc. $EXPO

Y Intercept Hong Kong Ltd bought a new stake in Exponent, Inc. (NASDAQ:EXPO) during the second quarter, HoldingsChannel reports. The fund bought 56,587 shares of the business services provider’s stock, valued at approximately $4,228,000.

Other institutional investors have also added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in Exponent by 10,200.0% during the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock valued at $25,000 after buying an additional 306 shares during the period. Bessemer Group Inc. boosted its position in Exponent by 103.3% during the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after buying an additional 346 shares during the period. SVB Wealth LLC purchased a new stake in Exponent during the first quarter valued at about $80,000. Caitong International Asset Management Co. Ltd boosted its position in Exponent by 8,092.9% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock valued at $93,000 after buying an additional 1,133 shares during the period. Finally, Covestor Ltd boosted its position in Exponent by 43.7% during the first quarter. Covestor Ltd now owns 1,785 shares of the business services provider’s stock valued at $145,000 after buying an additional 543 shares during the period. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Exponent currently has a consensus rating of “Hold”.

Exponent Price Performance

Shares of EXPO opened at $67.42 on Wednesday. Exponent, Inc. has a one year low of $63.81 and a one year high of $112.75. The company has a 50-day simple moving average of $69.36 and a two-hundred day simple moving average of $73.28. The firm has a market capitalization of $3.40 billion, a PE ratio of 33.71 and a beta of 0.91.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. During the same period last year, the business posted $0.57 earnings per share. Exponent’s quarterly revenue was up 7.3% compared to the same quarter last year. Analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Insider Buying and Selling

In other Exponent news, VP Joseph Sala sold 1,595 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total transaction of $112,670.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Catherine Corrigan sold 4,930 shares of the firm’s stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of $66.82, for a total transaction of $329,422.60. Following the transaction, the chief executive officer directly owned 82,753 shares of the company’s stock, valued at $5,529,555.46. This represents a 5.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 16,326 shares of company stock valued at $1,133,059 in the last ninety days. Insiders own 1.60% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.